| Catherine D'auberville Harding, MD | |
|
801 Goodyear Ave, Gadsden, AL 35903-1133 | |
| (205) 685-8036 | |
| (205) 685-8077 |
| Full Name | Catherine D'auberville Harding |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 801 Goodyear Ave, Gadsden, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144277229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 00018499 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Catherine D'auberville Harding, MD Po Box 1223, Calera, AL 35040-1223 Ph: (205) 685-8036 | Catherine D'auberville Harding, MD 801 Goodyear Ave, Gadsden, AL 35903-1133 Ph: (205) 685-8036 |
News Archive
T-cell therapy, a form of immunotherapy that uses a patient's own immune cells to attack their cancer, has been making waves recently. The "living" therapy involves engineering the patient's T cells in the laboratory to carry new proteins that guide the immune cells directly to tumor cells, allowing the engineered T cells to attack and kill the cancer.
American Bio Medica Corporation announced today its financial results for the three months ended March 31, 2010.
United American Healthcare Corporation today announced financial results for the Company's fiscal first quarter ended Sept. 30, 2010, which included higher revenues and improved bottom line results.
Cubist Pharmaceuticals, Inc., a leading acute care therapeutics company, today announced the enrollment and dosing of the first subject in its Phase 2 trial with CB-183,315, an antibacterial drug candidate intended to treat patients with a severe and sometimes life-threatening diarrhea caused by Clostridium difficile known as C. difficile-associated diarrhea, or CDAD. The trial is expected to enroll more than 200 subjects at 28 sites in the United States and Canada.
Researchers from the MassGeneral Institute for Neurodegenerative Disorders (MGH-MIND) have discovered how the death of brain cells caused by a stroke or head injury may cause generation of amyloid-beta protein ? the key component of senile plaques seen in the brains of patients with Alzheimer's disease.
› Verified 3 days ago
Vladimir Slutsker, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 801 Goodyear Ave, Gadsden, AL 35903 Phone: 256-439-5011 Fax: 256-439-5002 | |
Michael Kenneth Morris, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 W Meighan Blvd, Suite E, Gadsden, AL 35901 Phone: 256-547-6522 Fax: 256-543-7477 | |
Mollie Joan Strickland, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1007 Goodyear Ave, Gadsden, AL 35903 Phone: 256-413-6060 Fax: 256-413-6066 | |
Odeane H Connor, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 402 S 6th St, Gadsden, AL 35901 Phone: 256-546-9558 Fax: 256-546-9975 | |
Dr. Rey S Gavino, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 430 George Wallace Dr # 246, Gadsden, AL 35903 Phone: 256-343-1800 Fax: 256-365-1046 | |
Cameron Dean, Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 109 Argyle Ct, Gadsden, AL 35904 Phone: 256-490-7238 |